LAMEA Hyaluronic Acid-Based Dermal Fillers Market Size | COVID-19 Impact Analysis | Forecast to 2025

The LAMEA hyaluronic acid-based dermal fillers market is estimated to grow at a CAGR of 7.4% during the forecast period. RoW countries include Brazil, Mexico and Colombia, Saudi Arabia and the United Arab Emirates (UAE). RoW dermal fillers market is estimated to grow significantly during the forecast period owing to the rising demand for non-surgical procedures coupled with the rising availability of filler options available in the Brazilian market. As a result, the companies are looking to expand the availability of their dermal fillers in these countries. For instance, in January 2018, Sinclair Pharma plc announced that it has received regulatory approval of Ellansé by ANVISA in Brazil. Brazil is considered as one of the major aesthetic dermatology markets with a considerable rise in the injectable procedures reported in 2017.

To Request a Sample of our Report on LAMEA Hyaluronic Acid-Based Dermal Fillers Market: https://www.omrglobal.com/request-sample/lamea-hyaluronic-acid-based-dermal-fillers-market

This is representing a significant demand for non-surgical cosmetic procedures in these countries. For instance, as per ISAPS, in Brazil, the number of injectable procedures was 677,765 in 2017, whereas, in Columbia, it was 125,350 in 2017. Due to such a rise in injectable procedures, a significant availability of plastic surgeons has been witnessed in 2017. For instance, as per the ISAPS, in 2017, the estimated number of plastic surgeons in Brazil was 5,500, while, the estimated number of plastic surgeons in Colombia was 1,000. The demand for this injectable procedure is anticipated to grow significantly in the region coupled with increasing disposable income across the countries, such as Saudi Arabia and UAE, which in turn, will likely drive the demand for dermal filler treatment in the region.

The LAMEA hyaluronic acid-based dermal fillers market can be segmented based on application and end-users. Based on the application, the market is classified into face-lift, lip treatment/enhancement, facial line correction treatment, and other applications. Based on end-user, the market is segmented into dermatology clinics and hospitals. Among types, the calcium hydroxylapatite is projected to exhibit a significant growth rate in the market due to technology advancement and new product development.

(Get 15% Discount on Buying this Report)

A full Report of LAMEA Hyaluronic Acid-Based Dermal Fillers Market is Available @ https://www.omrglobal.com/industry-reports/lamea-hyaluronic-acid-based-dermal-fillers-market

LAMEA Hyaluronic Acid-based Dermal Fillers Market Segmentation

By Application

· Face-Lift

· Lip Treatment/Enhancement

· Facial Line Correction Treatment

· Others (Acne Scar Treatment)

By End-User

· Dermatology Clinics

· Hospitals

REGIONAL ANALYSIS

· Brazil

· Argentina

· UAE

· South Africa

· Nigeria

Rest of LAMEA

COMPANY PROFILES

· Allergan PLC

· Anika Therapeutics, Inc.

· Croma-Pharma GmbH

· Cynosure LLC

· Galderma Laboratories, L.P.

· Huons Co. Ltd.

· Merz Pharmaceuticals GmbH

· Prollenium Medical Technologies, Inc.

· Sculpt Luxury Dermal Fillers Ltd.

· Suneva Medical, Inc.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.